Related Experiment Video
Updated: May 28, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Prevention and treatment of MS: studying the effects of vitamin D
Kassandra L Munger1, Alberto Ascherio
1Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA. kgorham@hsph.harvard.edu
Abstract:
Observational studies suggest that adequate vitamin D nutrition may reduce the risk of MS and affect the course of the disease. Inherent limitations in these studies, however, preclude a causal interpretation. Randomized controlled clinical trials are the next step to addressing whether vitamin D prevents MS or can favorably affect the course and progression of MS. Here we briefly review the current literature on vitamin D and MS, both as a risk factor and potential treatment for MS with a focus on the issues and challenges in designing prevention and treatment clinical trials.
Insights
Adequate vitamin D nutrition may lower multiple sclerosis (MS) risk and impact disease course, but observational studies lack causal evidence. Randomized trials are needed to confirm vitamin D
Area of Science:
- Neurology
- Immunology
- Nutritional Science
Background:
- Observational studies link adequate vitamin D to reduced multiple sclerosis (MS) risk and disease course.
- Limitations in observational studies prevent causal inference regarding vitamin D and MS.
- Vitamin D's role in MS pathogenesis and potential therapeutic benefits require further investigation.
Purpose of the Study:
- To review current literature on vitamin D and MS.
- To explore vitamin D as both a risk factor and potential treatment for MS.
- To highlight challenges in designing clinical trials for MS prevention and treatment.
Main Methods:
- Literature review of observational studies and clinical trials on vitamin D and MS.
- Analysis of existing data on vitamin D's association with MS risk and progression.
- Discussion of methodological issues in designing randomized controlled trials (RCTs) for vitamin D intervention in MS.
Main Results:
- Observational data suggest a correlation between vitamin D levels and MS risk/progression.
- Current evidence is insufficient to establish a causal relationship.
- Significant challenges exist in designing robust RCTs for vitamin D in MS prevention and treatment.
Conclusions:
- Vitamin D's potential role in MS warrants further investigation through rigorous clinical trials.
- Randomized controlled trials are essential to determine if vitamin D can prevent MS or modify its course.
- Addressing design challenges is crucial for advancing research on vitamin D for MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
What is an Experiment?
Vitamins
